Rare diseases
Investigational molecules
Locations
Back to Italy687 clinical trials in Turin, Italy across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Hydroxychloroquine for Improving Pregnancy Outcomes in Women with Antiphospholipid Antibodies
ItalyStudy on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure
ItalyStudy of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome
ItalyStudy on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions
ItalyStudy on Colchicine for Treating Patients with Inflammatory Cardiomyopathy
ItalyStudy on Lorundrostat for Patients with Uncontrolled and Resistant Hypertension
ItalyA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
ItalyEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
ItalyA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
ItalyStudy of navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
ItalyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
ItalyStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials in cardiovascular disease and intensive care are evaluating ways to improve survival, reduce bleeding risk, and strengthen symptom control in seriously ill patients. In Torino, this includes studies focused on heart inflammation, irregular heartbeat after stent treatment, and ventilation strategies for critically ill adults.
These studies are helping refine supportive care and test more effective approaches for common and potentially serious cardiac and critical care conditions.
Research in digestive system diseases is centered on ulcerative colitis, with trials designed to improve long-term disease control and assess new treatment options for patients with active inflammation. The work aims to support better symptom relief and maintain remission more reliably.
This area reflects a strong interest in treatments that can make daily life easier for people living with ongoing gastrointestinal inflammation.
A large share of the clinical trial activity in Torino involves cancer research, spanning solid tumors and blood cancers. Studies are exploring new therapies, treatment combinations, and maintenance approaches for conditions such as colorectal cancer, ovarian cancer, breast cancer, lymphoma, and multiple myeloma.
These trials aim to extend progression-free survival, improve response rates, and support more personalized treatment choices across several major oncology and hematology settings.
Several studies focus on children’s health, especially rare cancers and inherited disorders. Key areas include high-risk neuroblastoma, acute lymphoblastic leukemia, and other conditions where the goal is to improve survival and reduce relapse risk.
These trials support advances in pediatric oncology by evaluating newer treatment approaches and care strategies for young patients with serious illness.
Trials in infectious diseases are examining treatment options for Gram-negative infections and HIV-1, with the aim of improving infection management and supporting long-term viral suppression. The research also includes studies of antimicrobial use in younger patients.
This field combines antimicrobial research with efforts to make treatment more practical and effective across different patient groups.
Clinical research in female reproductive health addresses both fertility support and pregnancy-related complications. Studies are looking at ways to improve ovarian reserve, assist IVF care, and reduce risks for women with premature rupture of membranes.
These studies aim to support safer pregnancies and better fertility treatment options for patients and families.
Research in neurology and related muscle disorders includes treatment studies for spinal and bulbar muscular atrophy and approaches to reduce pain from low back pain. The broader goal is to improve function, symptom relief, and quality of life.
This area reflects a practical focus on conditions that can strongly affect independence and everyday comfort.
A number of trials are dedicated to rare and genetic conditions, including hereditary angioedema and PIK3CA-related overgrowth spectrum. These studies are focused on reducing attacks or managing abnormal tissue growth while improving long-term care.
The research is especially important for people with limited treatment options and complex genetic disease.
In skin and connective tissue diseases, trials are studying hidradenitis suppurativa, a painful inflammatory condition that can be difficult to control. The research is aimed at improving disease activity, comfort, and everyday functioning.
These studies reflect ongoing efforts to find more effective options for persistent dermatologic inflammation.
Research in musculoskeletal disease and related pain conditions includes studies on inflammatory or recurrent pain states where symptom relief is a major priority. The aim is to find treatments that reduce discomfort and help patients return to normal activity sooner.
This work supports better management of common but disabling pain disorders.
Clinical trials in urologic cancer are focusing on upper tract urothelial cancer, with a strong interest in improving tumor control and preserving treatment options. The research also includes advanced and resistant ovarian cancer settings linked to broader female urogenital disease research.
These studies aim to expand treatment choices in cancers that often require specialized care.
Some studies in Torino are not limited to one disease area but instead examine broader therapeutic techniques and treatment strategies. These trials evaluate how different approaches can improve outcomes, safety, or delivery of care across multiple specialties.
This kind of research helps refine how treatments are used in everyday practice across a wide range of medical fields.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
